Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Department of Cardiology, Medical Clinic I, University Hospital of the RWTH Aachen, Aachen, Germany.
Cardiovasc Res. 2022 Jul 20;118(9):2196-2210. doi: 10.1093/cvr/cvab244.
Smokers are at increased risk of cardiovascular events. However, the exact mechanisms through which smoking influences cardiovascular disease resulting in accelerated atherosclerosis and vascular calcification are unknown. The aim of this study was to investigate effects of nicotine on initiation of vascular smooth muscle cell (VSMC) calcification and to elucidate underlying mechanisms.
We assessed vascular calcification of 62 carotid lesions of both smoking and non-smoking patients using ex vivo micro-computed tomography (µCT) scanning. Calcification was present more often in carotid plaques of smokers (n = 22 of 30, 73.3%) compared to non-smokers (n = 11 of 32, 34.3%; P < 0.001), confirming higher atherosclerotic burden. The difference was particularly profound for microcalcifications, which was 17-fold higher in smokers compared to non-smokers. In vitro, nicotine-induced human primary VSMC calcification, and increased osteogenic gene expression (Runx2, Osx, BSP, and OPN) and extracellular vesicle (EV) secretion. The pro-calcifying effects of nicotine were mediated by Ca2+-dependent Nox5. SiRNA knock-down of Nox5 inhibited nicotine-induced EV release and calcification. Moreover, pre-treatment of hVSMCs with vitamin K2 ameliorated nicotine-induced intracellular oxidative stress, EV secretion, and calcification. Using nicotinic acetylcholine receptor (nAChR) blockers α-bungarotoxin and hexamethonium bromide, we found that the effects of nicotine on intracellular Ca2+ and oxidative stress were mediated by α7 and α3 nAChR. Finally, we showed that Nox5 expression was higher in carotid arteries of smokers and correlated with calcification levels in these vessels.
In this study, we provide evidence that nicotine induces Nox5-mediated pro-calcific processes as novel mechanism of increased atherosclerotic calcification. We identified that activation of α7 and α3 nAChR by nicotine increases intracellular Ca2+ and initiates calcification of hVSMCs through increased Nox5 activity, leading to oxidative stress-mediated EV release. Identifying the role of Nox5-induced oxidative stress opens novel avenues for diagnosis and treatment of smoking-induced cardiovascular disease.
吸烟者患心血管事件的风险增加。然而,吸烟影响心血管疾病导致动脉粥样硬化加速和血管钙化的确切机制尚不清楚。本研究旨在探讨尼古丁对血管平滑肌细胞(VSMC)钙化启动的影响,并阐明其潜在机制。
我们使用离体微计算机断层扫描(µCT)扫描评估了 62 例颈动脉病变患者(吸烟和非吸烟患者各 32 例)的血管钙化情况。与非吸烟者(32 例中有 11 例,34.3%)相比,吸烟者(30 例中有 22 例,73.3%)颈动脉斑块中更常出现钙化,证实了更高的动脉粥样硬化负担。这种差异在微钙化中尤为明显,吸烟者的微钙化程度是非吸烟者的 17 倍。在体外,尼古丁诱导人原代 VSMC 钙化,并增加成骨基因表达(Runx2、Osx、BSP 和 OPN)和细胞外囊泡(EV)分泌。尼古丁的促钙化作用是通过 Ca2+依赖性 Nox5 介导的。Nox5 的 siRNA 敲低抑制了尼古丁诱导的 EV 释放和钙化。此外,用维生素 K2 预处理 hVSMCs 可改善尼古丁诱导的细胞内氧化应激、EV 分泌和钙化。使用烟碱型乙酰胆碱受体(nAChR)阻滞剂α-银环蛇毒素和六烃季铵,我们发现尼古丁对细胞内 Ca2+和氧化应激的影响是通过α7 和α3 nAChR 介导的。最后,我们表明吸烟者颈动脉中的 Nox5 表达更高,并与这些血管中的钙化水平相关。
在这项研究中,我们提供了证据表明,尼古丁诱导 Nox5 介导的促钙化过程是动脉粥样硬化性钙化增加的新机制。我们发现,尼古丁激活α7 和α3 nAChR 会增加细胞内 Ca2+,并通过增加 Nox5 活性引发 hVSMCs 的钙化,从而导致氧化应激介导的 EV 释放。鉴定 Nox5 诱导的氧化应激的作用为诊断和治疗吸烟引起的心血管疾病开辟了新途径。